Sonja Potrebic
YOU?
Author Swipe
View article: Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention
Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention Open
Objective To provide updated evidence‐based recommendations for migraine prevention using pharmacologic treatment with or without cognitive behavioral therapy in the pediatric population. Methods The authors systematically reviewed literat…
View article: Practice guideline update summary: Acute treatment of migraine in children and adolescents
Practice guideline update summary: Acute treatment of migraine in children and adolescents Open
Recommendations for the treatment of acute migraine in children and adolescents focus on the importance of early treatment, choosing the route of administration best suited to the characteristics of the individual migraine attack, and prov…
View article: Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention
Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention Open
The majority of randomized controlled trials studying the efficacy of preventive medications for pediatric migraine fail to demonstrate superiority to placebo. Recommendations for the prevention of migraine in children include counseling o…
View article: Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis
Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis Open
Objective To review evidence on starting, switching, and stopping disease-modifying therapies (DMTs) for multiple sclerosis (MS) in clinically isolated syndrome (CIS), relapsing-remitting MS (RRMS), and progressive MS forms. Methods Releva…
View article: Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis
Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis Open
Objective To develop recommendations for disease-modifying therapy (DMT) for multiple sclerosis (MS). Methods A multidisciplinary panel developed DMT recommendations, integrating findings from a systematic review; followed an Institute of …
View article: Naturalistic study of guideline implementation tool use via evaluation of website access and physician survey
Naturalistic study of guideline implementation tool use via evaluation of website access and physician survey Open
Developers faced with resource limitations may wish to prioritize the development of printable or mobile application clinician summaries, which were accessed significantly more than other types of GItools. Further research is needed to und…
View article: Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache [RETIRED]
Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache [RETIRED] Open
Blepharospasm: OnabotulinumtoxinA (onaBoNT-A) and incobotulinumtoxinA (incoBoNT-A) are probably effective and should be considered (Level B). AbobotulinumtoxinA (aboBoNT-A) is possibly effective and may be considered (Level C). CD: AboBoNT…